Compare FLNA & USIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FLNA | USIO |
|---|---|---|
| Founded | 1998 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.8M | 58.8M |
| IPO Year | 2000 | 1999 |
| Metric | FLNA | USIO |
|---|---|---|
| Price | $0.74 | $2.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 4.3M | 282.4K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | ★ $41,119,000.00 | $28,200,535.00 |
| Revenue This Year | N/A | $12.15 |
| Revenue Next Year | N/A | $8.57 |
| P/E Ratio | ★ N/A | $228.00 |
| Revenue Growth | N/A | ★ 12.69 |
| 52 Week Low | $0.67 | $1.03 |
| 52 Week High | $2.03 | $3.06 |
| Indicator | FLNA | USIO |
|---|---|---|
| Relative Strength Index (RSI) | 43.49 | 44.58 |
| Support Level | $0.67 | $2.15 |
| Resistance Level | $1.02 | $2.61 |
| Average True Range (ATR) | 0.09 | 0.16 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 12.86 | 25.90 |
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
Usio Inc is a cloud-based Fintech payment processor. The company serves multiple industry verticals with technology that facilitates payment acceptance and funds disbursement in a single, full-stack ecosystem. It provides payment acceptance through multiple payment methods, including payment facilitation, prepaid card, and electronic billing products and services to businesses, merchants, and consumers. The company's reportable operating segments are Output Solutions and Merchant Services, and these segments.